Skip to main navigation
Skip to search
Skip to main content
Chang Gung University Academic Capacity Ensemble Home
Help & FAQ
English
中文
Home
Profiles
Research units
Research output
Projects
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
A one-year trial of lamivudine for chronic hepatitis B
Ching Lung Lai
*
, Rong Nan Chien
, Nancy W.Y. Leung
, Ting Tsung Chang
, Richard Guan
, Dar In Tai
, Keng Yeen Ng
, Pui Chee Wu
, Julie C. Dent
, Judy Barber
, Sally L. Stephenson
, D. Fraser Gray
*
Corresponding author for this work
Queen Mary Hospital Hong Kong
The University of Hong Kong
Chang Gung Memorial Hospital
The Chinese University of Hong Kong
National Cheng Kung University
National University Hospital
Singapore General Hospital
Glaxo Wellcome China
GlaxoSmithKline
Research output
:
Contribution to journal
›
Journal Article
›
peer-review
1818
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A one-year trial of lamivudine for chronic hepatitis B'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
9%
Alanine Aminotransferase
9%
Antibody
9%
Base
9%
Blindness
9%
Chronic Hepatitis B
100%
DNA
18%
Fibrosis
9%
Hepatitis B Virus
18%
Hepatitis B(e) Antigen
27%
Incidence
9%
Lamivudine
100%
Nucleoside Analog
9%
Placebo
45%